Affordable Access

Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.

Authors
Type
Published Article
Journal
Prostate cancer and prostatic diseases
Publication Date
Volume
9
Issue
1
Pages
92–98
Identifiers
PMID: 16231013
Source
Medline

Abstract

Statistics

Seen <100 times